Company Intelligence

Empirical Health

Don't die of heart disease. While heart disease is the #1 killer worldwide, 80% of heart disease is preventable. Empirical's program starts with an advanced lab test with 100+ biomarkers, including ApoB, Lp(a), inflammation, and more.…

In this profile

Quick Facts

  • Founded 2023
  • Headquarters New York City, United States
  • Country United States
  • Industry AI in Healthcare
  • Company Type Early
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Don't die of heart disease. While heart disease is the #1 killer worldwide, 80% of heart disease is preventable.

Empirical's program starts with an advanced lab test with 100+ biomarkers, including ApoB, Lp(a), inflammation, and more. Then, we help you model your lifetime risk of heart disease and generate a plan to reduce your risk to an optimal level. Then we help you achieve that plan.

Empirical is licensed, registered, and insured to deliver real medical care in 30+ US states covering 200m+ people. We're growing >25% monthly.

Why It Matters

Don't die of heart disease. Empirical is the first AI-native heart…

Recent Developments

  1. 2023 Company founded

    Empirical Health was founded in 2023 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Don’t die of heart disease. While heart disease is the #1 killer worldwide, 80% of heart disease is preventable.

Empirical’s program starts with an advanced lab test with 100+ biomarkers, including ApoB, Lp(a), inflammation, and more. Then, we help you model your lifetime risk of heart disease and generate a plan to reduce your risk to an optimal level. Then we help you achieve that plan.

Empirical is licensed, registered, and insured to deliver real medical care in 30+ US states covering 200m+ people. We’re growing >25% monthly.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe